This article systematically summarizes key experimental strategies, technical challenges, and standardization recommendations in extracellular vesicle (EV) research, providing a comprehensive methodological framework for the isolation and characterization of EVs from diverse sources.
Literature Overview
The article 'Extracellular Vesicle Analysis,' published in Nature Reviews Methods Primers, reviews and summarizes the multi-step workflows for isolating, characterizing, and applying extracellular vesicles (EVs) across various ecosystems. It systematically outlines experimental design principles from sample source selection and EV preparation to quality control and downstream functional studies. The article emphasizes the advantages, limitations, and standardization challenges of different technical approaches, aiming to provide researchers with a cross-disciplinary, reproducible methodological framework for EV research. Additionally, it discusses the potential of EVs in fundamental biology, disease diagnosis, and therapy, along with future research directions. The entire section is coherent and logically structured, ending with a Chinese period.Background Knowledge
Extracellular vesicles (EVs) are a class of nano-sized membrane structures released by cells, widely present in bodily fluids, cell culture supernatants, and environmental samples. They mediate intercellular communication by carrying biomolecules such as proteins, nucleic acids, and lipids. Based on their biogenesis, EVs can be subdivided into exosomes, microvesicles, and apoptotic bodies. However, due to overlapping structural and compositional features, the general term 'extracellular vesicles' is now widely adopted. EVs play crucial roles in both physiological and pathological processes—such as immune regulation, tumor microenvironment formation, and the progression of neurodegenerative diseases—and are therefore considered promising candidates for liquid biopsy biomarkers and drug delivery vehicles. Nevertheless, EV research faces multiple challenges: samples often contain abundant non-EV particles (e.g., lipoproteins, viral particles), EVs are highly heterogeneous, and different isolation methods—such as ultracentrifugation, size-exclusion chromatography, and affinity capture—vary significantly in recovery efficiency and purity for specific EV subpopulations. Moreover, the lack of standardized protocols makes cross-study comparisons difficult. Current research focuses on improving the specificity and reproducibility of EV isolation, developing high-sensitivity characterization techniques, and exploring applications in disease diagnosis (e.g., cancer, neurodegenerative diseases) and therapy (e.g., engineered EVs as drug carriers). Against this backdrop, this study systematically integrates existing methodologies to propose EV analysis strategies that balance efficiency and specificity, advancing the field toward standardization and translational applications.
Research Methods and Experiments
The article systematically outlines the entire workflow of EV research, covering steps such as sample source selection, pre-processing, concentration, enrichment, isolation, and storage. For various sources—including blood, urine, cell culture supernatants, plant sap, and seawater—the authors analyze coexisting non-EV components (e.g., lipoproteins, protein aggregates, cell debris) and emphasize the importance of transparently reporting pre-analytical parameters. EV preparation strategies are tailored to the target EV subpopulation and downstream applications, combining multiple techniques: size-based methods such as ultrafiltration, size-exclusion chromatography (SEC), and asymmetric flow field-flow fractionation (AF4); density-based methods like gradient centrifugation; and surface-antigen-based affinity capture. The authors provide a detailed comparison of each method’s performance in terms of efficiency, specificity, throughput, and cost, noting that multi-step combinations can enhance purity but may reduce recovery yield. For EV characterization, orthogonal methods are recommended—including nanoparticle tracking analysis (NTA), flow cytometry, electron microscopy, and immunoblotting—to assess EV size, concentration, morphology, surface markers, and cargo. The article also stresses the need to detect non-EV markers (e.g., albumin, apolipoproteins) to evaluate preparation purity. Experimental design should balance performance metrics according to research goals: for basic research, lower purity may be acceptable to preserve a broader range of EV subpopulations, whereas diagnostic or therapeutic applications demand high specificity.Key Conclusions and Perspectives
Research Significance and Prospects
This review provides a systematic methodological guide for EV research, helping scientists understand the scope and limitations of different techniques to design more rigorous and reproducible experiments. By advocating for standardization and transparency, the article promotes higher scientific rigor in the EV field and helps address the current problem of non-comparable data due to methodological variability.
At the application level, this framework supports the discovery and validation of EVs as disease biomarkers, particularly in liquid biopsy for cancer and neurodegenerative diseases. Furthermore, a deeper understanding of EV purification and characterization provides a technical foundation for developing EV-based therapeutic carriers (e.g., engineered exosomes). In the future, as high-sensitivity single-vesicle analysis techniques and multi-omics integration advance, EV research is expected to uncover finer details of intercellular communication networks, driving progress in precision medicine.
Conclusion
This article comprehensively summarizes the methodological advances and challenges in extracellular vesicle (EV) research, proposing a systematic EV analysis framework that covers the entire process from sample preparation to functional validation. The authors emphasize that due to the high heterogeneity of EVs and the abundance of interfering particles in samples, no single method can optimally balance purity and recovery. Therefore, appropriate technical combinations must be selected based on research objectives. Orthogonal characterization and transparent reporting are key to ensuring data reliability and reproducibility. This review not only provides a practical guide for fundamental EV research but also establishes a methodological foundation for the translational application of EVs in disease diagnosis and therapy. As techniques continue to improve and become standardized, EVs are poised to become a crucial bridge between basic science and clinical practice, advancing the development of liquid biopsy and targeted therapeutics. This work holds significant reference value for researchers, clinicians, and biotechnology developers.
